M
MedVantx
Innovative consumer medication management and delivery company committed to reducing costs
About MedVantx
Medvantx operates in the pharmaceutical distribution market, offering a direct-to-patient platform that connects pharmaceutical manufacturers directly with patients. The company leverages e-commerce and innovative final mile fulfillment services to ensure faster and more efficient delivery of medications. Medvantx serves pharmaceutical manufacturers looking to streamline their distribution processes and improve patient access to medications. The business model revolves around providing a seamless distribution channel that bypasses traditional intermediaries, thus reducing costs and improving delivery times. Medvantx generates revenue through service fees charged to pharmaceutical manufacturers for using its platform and fulfillment services. The company is accredited by the National Association of Boards of Pharmacy, ensuring high standards of quality, safety, and security.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2002
- Headquarters
- San Diego, United States
- Employees
- 187
- Open positions
- 6
- Dealroom signal
- 64.5/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Supply Chain Management, Arts & Culture, Hard Tech
- Client focus
- b2b
- Investment activity
- 1 company, latest Jul 2025
- Capital deployed
- —
- Preferred round
- ACQUISITION
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| DEBTDebt | Dec 2014 | $0 | — | Saints Capital | — |
| SERIES DOther financing | May 2005 | $11M | $42M | ARCH Venture Partners · Oakwood Medical Investors | — |
Growth signals
Latest recorded traffic for MedVantx is 20K monthly website visits, up 354.5% over the last three months. MedVantx's team declined 4.1% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series B and later4 investors entered at this stage
Polaris Partners
ARCH Venture Partners- OIOakwood Medical Investors
Saints Capital
Other known investors1 additional known investor
Ironwood Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about MedVantx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See MedVantx’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.